1612 — Vincent Medical Holdings Cashflow Statement
0.000.00%
Last trade - 00:00
- HK$307.07m
- HK$169.92m
- HK$717.97m
- 96
- 98
- 80
- 100
2019 December 31st | C2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 18.3 | 284 | 66.2 | -15.5 | 66.9 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 17.4 | 68 | 42.9 | 47.6 | 6.48 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -33.1 | -181 | -30.1 | 2.71 | 13.3 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 31.2 | 208 | 119 | 75.8 | 125 |
Capital Expenditures | -31.1 | -55.8 | -25 | -18.6 | -63.7 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -2.7 | -10.1 | 4.43 | 0.5 | 1.33 |
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Change in Net Intangibles | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -33.8 | -65.9 | -20.5 | -18.1 | -62.4 |
Financing Cash Flow Items | 1.2 | -85.6 | 0.209 | 0 | -0.08 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -5.41 | -59.5 | -101 | -67.8 | -45.4 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -11.2 | 99.1 | 4.1 | -13.8 | 16.4 |